Kymera Therapeutics, Inc.
KYMR
52 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Jul 8 12:00 AM | Nello MainolfiDirector, Chief Executive Officer | Sale | 50,000 | $119.00 | $6.0M | 666,568(D) | View → |
| Jul 7, 2026 | Jul 7 8:07 PM | Mainolfi Nello | Proposed Sale | 50,000 | $119.00 | $6.0M | — | View → |
| Jun 30, 2026 | Jul 2 10:30 PM | Bruce N. JacobsChief Financial Officer | Sale | 77,109 | $114.96 | $8.9M | 244,883(D) | View → |
| Jul 1, 2026 | Jul 2 10:30 PM | Noah GoodmanChief Business Officer | Sale | 3,389 | $114.29 | $387.3K | 47,179.438(D) | View → |
| Jul 1, 2026 | Jul 2 10:30 PM | Nello MainolfiDirector, Chief Executive Officer | Sale | 80,000 | $115.29 | $9.2M | 666,568(D) | View → |
| Jun 29, 2026 | Jul 2 9:39 PM | Bruce BoothDirector | Sale | 76,650 | $108.05 | $8.3M | 462,856(I) | View → |
| Jul 1, 2026 | Jul 2 12:33 PM | Mainolfi Nello | Proposed Sale | 80,000 | $114.29 | $9.1M | — | View → |
| Jul 1, 2026 | Jul 1 8:58 PM | NOAH GOODMAN | Proposed Sale | 3,389 | $114.67 | $388.6K | — | View → |
| Jun 29, 2026 | Jun 30 9:32 PM | Bruce BoothDirector | Sale | 31,283 | $109.48 | $3.4M | 461,794(I) | View → |
| Jun 29, 2026 | Jun 30 9:30 PM | Bruce BoothDirector | Sale | 45,367 | $107.06 | $4.9M | 466,077(I) | View → |
| Jun 26, 2026 | Jun 30 9:30 PM | Bruce BoothDirector | Sale | 467,878 | $110.29 | $51.6M | 472,267(I) | View → |
| Jun 30, 2026 | Jun 30 8:32 PM | BRUCE N. JACOBS | Proposed Sale | 77,109 | $109.32 | $8.4M | — | View → |
| Jun 29, 2026 | Jun 29 9:51 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 10,473 | $108.12 | $1.1M | — | View → |
| Jun 29, 2026 | Jun 29 9:51 PM | Atlas Venture Fund X, LP | Proposed Sale | 66,177 | $108.12 | $7.2M | — | View → |
| Jun 26, 2026 | Jun 26 10:48 PM | P/Il L Bvf PartnersDirector, Other | Sale | 1,630,658 | $106.50 | $173.7M | 78,787(I) | View → |
| Jun 26, 2026 | Jun 26 10:13 PM | BVF PARTNERS L P/IL | Proposed Sale | 1,630,658 | $116.46 | $189.9M | — | View → |
| Jun 26, 2026 | Jun 26 8:52 PM | Atlas Venture Fund X, LP | Proposed Sale | 410,427 | $116.46 | $47.8M | — | View → |
| Jun 26, 2026 | Jun 26 8:51 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 57,451 | $116.46 | $6.7M | — | View → |
| Jun 25, 2026 | Jun 26 1:56 AM | Bruce BoothDirector | Sale | 285,684 | $121.86 | $34.8M | 529,718(I) | View → |
| Jun 25, 2026 | Jun 26 1:55 AM | Bruce BoothDirector | Sale | 262,637 | $115.39 | $30.3M | 564,668(I) | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Apr 29 9:00 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 215,559(D) | View → |
| Apr 22, 2026 | Apr 24 8:33 PM | Bruce BoothDirector | Option Exercise | 5,900 | $20.00 | 39,868(D) | View → |
| Apr 22, 2026 | Apr 24 8:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 300 | $43.50 | 58,263(D) | View → |
| Apr 15, 2026 | Apr 16 10:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 1,300 | $43.50 | 58,463(D) | View → |
| Apr 14, 2026 | Apr 16 10:30 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 5,251 | $43.50 | 59,763(D) | View → |
| Apr 15, 2026 | Apr 16 10:16 PM | Bruce BoothDirector | Option Exercise | 2,200 | $14.18 | 5,641(D) | View → |
| Apr 14, 2026 | Apr 16 10:16 PM | Bruce BoothDirector | Option Exercise | 4,159 | $14.18 | 7,841(D) | View → |
| Apr 9, 2026 | Apr 10 8:45 PM | Noah GoodmanChief Business Officer | Option Exercise | 2,500 | $21.05 | 97,500(D) | View → |
| Apr 1, 2026 | Apr 1 11:00 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 14,640 | $29.64 | 68,633(D) | View → |
| Apr 1, 2026 | Apr 1 11:00 PM | Elena RidloffDirector | Option Exercise | 4,600 | $14.18 | 0(D) | View → |
| Mar 31, 2026 | Apr 1 11:00 PM | Elena RidloffDirector | Option Exercise | 7,400 | $14.18 | 4,600(D) | View → |
| Mar 31, 2026 | Apr 1 11:00 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 7,600 | $29.64 | 83,273(D) | View → |
| Mar 25, 2026 | Mar 25 9:15 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 24,727 | $29.64 | 90,873(D) | View → |
| Mar 23, 2026 | Mar 25 9:15 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 84,400 | $29.64 | 115,600(D) | View → |
| Mar 20, 2026 | Mar 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 0(D) | View → |
| Mar 11, 2026 | Mar 11 10:51 PM | Jeremy G ChadwickChief Operating Officer | Option Exercise | 20,000 | $43.50 | 60,548(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Brian AdamsChief Legal Officer | Grant/Award | 8,250 | $90.10 | 8,250(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jeremy G ChadwickChief Operating Officer | Grant/Award | 25,150 | $90.10 | 25,150(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Noah GoodmanChief Business Officer | Grant/Award | 18,450 | $90.10 | 18,450(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |